Get in touch

Submit

Thank you

There are multiple criteria which must be met in order to qualify for access to the Patent Box. It can only be accessed by companies that are headquartered in the UK and where the main research and development nexus is also within the UK.

If your business qualifies, you could benefit from a significant discount on corporation tax in relation to the profits derived from the patented invention. What is more, if your patented technology only contributes to one small element of a wider product, you may qualify for the tax exemption on the value of the product as a whole. In this respect, the Patent Box can be a very generous benefit and which makes it popular for innovative companies looking to manage their tax exposure in the UK.

 

Patent Box - the Keltie difference

Our attorneys have witnessed first hand how the Patent Box system successfully stimulates innovation. In spite of this , many innovative British businesses are not using it. Whilst awareness of similar initiatives such as R&D tax Credits is high, awareness of the Patent Box is still relatively low - as of 2021 it is estimated that a majority of companies involved in innovating in the UK are not accessing the scheme.

 

Keltie offers comprehensive audits of your technology and technology processes, to help determine whether or not you are generating the kind of innovations that might enable you to qualify for the Patent Box.

 

This where we add value - by getting involved in the earliest stages of planning and developing an innovation, we can help access and unlock the benefits of the scheme. Our experienced attorneys will advise on whether Patent Box considerations should be built into your intellectual property strategy and portfolio, so you can capitalise on the value of your innovations.

 

Contact our skilled patent attorneys today to find out whether your innovation could enable you can start enjoying the benefits of the Patent Box.

Continue reading about Patent Box
More
Case Law Review: Board of Appeal Decision T 1741/22

29.04.2025

Case Law Review: Board of Appeal Decision T 1741/22

Patent applications related to data processing often fall foul of the EPO’s exclusions on “mathematical methods”. Applicants in the MedTech space in particular may find it far easier to protect the hardware in their wearable devices and tools than to protect the software that processes and analyses that data. A recent board of appeal decision T 1741/22 seems to contradict the Guidelines for Examination and previous Board of Appeal decisions. This decision may shed some light on how the EPO may approach these data processing applications in future.

More
Inventive step at the EPO for AI inventions – T 2803/18

16.08.2023

Inventive step at the EPO for AI inventions – T 2803/18

Assessment of inventive step at the European Patent Office is made with reference to the technical effect of the claimed invention. In particular, only those features of a claim that contribute to the technical character of an invention may be taken into account when determining whether an inventive step is present.

More
Generative AI and Copyright

04.07.2025

Generative AI and Copyright

The launch of OpenAI’s ChatGPT in November 2022 brought generative AI to the forefront, transforming how people work and create. Since then, models that can process and generate not only text but also images, audio, and video have gained momentum. However, these advancements raise significant copyright concerns: generative AI uses copyrighted materials for training and produces realistic, original content, thus challenging traditional concepts of authorship and originality.

More
SynbiTECH 2025

09.12.2025 - 10.12.2025

SynbiTECH 2025

Keltie is proud to be sponsoring and exhibiting at SynbiTECH 2025. Laura Kehoe, Asawari Churi, and Devanand Crease will be attending, with Devanand speaking on the second day.

Get in touch

Submit

Thank you